These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


355 related items for PubMed ID: 22227074

  • 1. Prognosis of an abnormal one-leg balance in community-dwelling patients with Alzheimer's disease: a 2-year prospective study in 686 patients of the REAL.FR study.
    Sourdet S, van Kan GA, Soto ME, Houles M, Cantet C, Nourhashemi F, Vellas B, Pahor M, Rolland Y.
    J Am Med Dir Assoc; 2012 May; 13(4):407.e1-6. PubMed ID: 22227074
    [Abstract] [Full Text] [Related]

  • 2. An abnormal "one-leg balance" test predicts cognitive decline during Alzheimer's disease.
    Rolland Y, Abellan van Kan G, Nourhashemi F, Andrieu S, Cantet C, Guyonnet-Gillette S, Vellas B.
    J Alzheimers Dis; 2009 May; 16(3):525-31. PubMed ID: 19276547
    [Abstract] [Full Text] [Related]

  • 3. Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer's disease.
    Soto ME, Secher M, Gillette-Guyonnet S, Abellan van Kan G, Andrieu S, Nourhashemi F, Rolland Y, Vellas B.
    J Alzheimers Dis; 2012 May; 28(3):647-54. PubMed ID: 22045479
    [Abstract] [Full Text] [Related]

  • 4. Diabetes mellitus as a modulator of functional impairment and decline in Alzheimer's disease. The Real.FR cohort.
    Sanz CM, Hanaire H, Vellas BJ, Sinclair AJ, Andrieu S, REAL.FR Study Group.
    Diabet Med; 2012 Apr; 29(4):541-8. PubMed ID: 21913970
    [Abstract] [Full Text] [Related]

  • 5. Predictive value of rapid decline in mini mental state examination in clinical practice for prognosis in Alzheimer's disease.
    Soto ME, Andrieu S, Cantet C, Reynish E, Ousset PJ, Arbus C, Gillette-Guyonnet S, Nourhashémi F, Vellas B, REAL.FR group.
    Dement Geriatr Cogn Disord; 2008 Apr; 26(2):109-16. PubMed ID: 18617740
    [Abstract] [Full Text] [Related]

  • 6. Predicting disease progression in Alzheimer's disease: the role of neuropsychiatric syndromes on functional and cognitive decline.
    Palmer K, Lupo F, Perri R, Salamone G, Fadda L, Caltagirone C, Musicco M, Cravello L.
    J Alzheimers Dis; 2011 Apr; 24(1):35-45. PubMed ID: 21157019
    [Abstract] [Full Text] [Related]

  • 7. Mortality in Alzheimer's disease: a comparative prospective Korean study in the community and nursing homes.
    Suh GH, Kil Yeon B, Shah A, Lee JY.
    Int J Geriatr Psychiatry; 2005 Jan; 20(1):26-34. PubMed ID: 15578675
    [Abstract] [Full Text] [Related]

  • 8. Living Alone with Alzheimer's Disease and the Risk of Adverse Outcomes: Results from the Plan de Soin et d'Aide dans la maladie d'Alzheimer Study.
    Soto M, Andrieu S, Gares V, Cesari M, Gillette-Guyonnet S, Cantet C, Vellas B, Nourhashémi F.
    J Am Geriatr Soc; 2015 Apr; 63(4):651-8. PubMed ID: 25900483
    [Abstract] [Full Text] [Related]

  • 9. Urinary incontinence and its association with death, nursing home admission, and functional decline.
    Holroyd-Leduc JM, Mehta KM, Covinsky KE.
    J Am Geriatr Soc; 2004 May; 52(5):712-8. PubMed ID: 15086650
    [Abstract] [Full Text] [Related]

  • 10. Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services.
    Wattmo C, Londos E, Minthon L.
    Clin Interv Aging; 2014 May; 9():1951-62. PubMed ID: 25484578
    [Abstract] [Full Text] [Related]

  • 11. Predictors of nursing home admission among Alzheimer's disease patients with psychosis and/or agitation.
    Miller EA, Schneider LS, Rosenheck RA.
    Int Psychogeriatr; 2011 Feb; 23(1):44-53. PubMed ID: 20214847
    [Abstract] [Full Text] [Related]

  • 12. Long-term progression of Alzheimer's disease in patients under antidementia drugs.
    Gillette-Guyonnet S, Andrieu S, Nourhashemi F, Gardette V, Coley N, Cantet C, Gauthier S, Ousset PJ, Vellas B, REAL.FR study group.
    Alzheimers Dement; 2011 Nov; 7(6):579-92. PubMed ID: 22055975
    [Abstract] [Full Text] [Related]

  • 13. Prognostic differences of the Mini Nutritional Assessment short form and long form in relation to 1-year functional decline and mortality in community-dwelling older adults receiving home care.
    Kiesswetter E, Pohlhausen S, Uhlig K, Diekmann R, Lesser S, Uter W, Heseker H, Stehle P, Sieber CC, Volkert D.
    J Am Geriatr Soc; 2014 Mar; 62(3):512-7. PubMed ID: 24611678
    [Abstract] [Full Text] [Related]

  • 14. Failure to regain function at 3 months after acute hospital admission predicts institutionalization within 12 months in older patients.
    Portegijs E, Buurman BM, Essink-Bot ML, Zwinderman AH, de Rooij SE.
    J Am Med Dir Assoc; 2012 Jul; 13(6):569.e1-7. PubMed ID: 22572555
    [Abstract] [Full Text] [Related]

  • 15. Wandering behavior and Alzheimer disease. The REAL.FR prospective study.
    Rolland Y, Andrieu S, Cantet C, Morley JE, Thomas D, Nourhashemi F, Vellas B.
    Alzheimer Dis Assoc Disord; 2007 Jul; 21(1):31-8. PubMed ID: 17334270
    [Abstract] [Full Text] [Related]

  • 16. Prognosis of Alzheimer's disease today: a two-year prospective study in 686 patients from the REAL-FR Study.
    Cortes F, Nourhashémi F, Guérin O, Cantet C, Gillette-Guyonnet S, Andrieu S, Ousset PJ, Vellas B, REAL-FR Group.
    Alzheimers Dement; 2008 Jan; 4(1):22-9. PubMed ID: 18631947
    [Abstract] [Full Text] [Related]

  • 17. Predictive validity of neuropsychiatric subgroups on nursing home placement and survival in patients with Alzheimer disease.
    Tun SM, Murman DL, Long HL, Colenda CC, von Eye A.
    Am J Geriatr Psychiatry; 2007 Apr; 15(4):314-27. PubMed ID: 17384314
    [Abstract] [Full Text] [Related]

  • 18. Construct validity of a modified bathroom scale that can measure balance in elderly people.
    Vermeulen J, Neyens JC, Spreeuwenberg MD, van Rossum E, Hewson DJ, Duchêne J, de Witte LP.
    J Am Med Dir Assoc; 2012 Sep; 13(7):665.e1-5. PubMed ID: 22809553
    [Abstract] [Full Text] [Related]

  • 19. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [Abstract] [Full Text] [Related]

  • 20. Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition.
    Lopez OL, Becker JT, Saxton J, Sweet RA, Klunk W, DeKosky ST.
    J Am Geriatr Soc; 2005 Jan; 53(1):83-7. PubMed ID: 15667381
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.